Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-12

Clinical Trial Update: Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether adding lactoferrin to oral iron improves anemia in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lactoferrin + oral iron (unknown brand/formulation)

Snippet

Sponsor: Alexandria University | Conditions: Anemia of Chronic Kidney Disease | Phase 4 | Status: UNKNOWN